Provention Bio | Investor Relations - Sec Filings
ProventionBio
News Careers Contact Us
Our approach Our team
Intercepting Autoimmune Disease Autoimmune Candidates Expanded Patient Access
Investor Information Corporate Governance Events and Webcasts Analyst Coverage Sec Filings Stock Chart
GettyImages-1253518405.jpg
About Us Our approach Our team Pipeline Intercepting Autoimmune Disease Autoimmune Candidates Expanded Patient Access Investors Investor Information Corporate Governance Events and Webcasts Analyst Coverage Sec Filings Stock Chart News Careers Contact Us
ProventionBio
 
 
 

Investors

Sec Filings

0001695357
YearTrailing 12-MonthsCalendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Mergers & AcquisitionsProxy & Information StatementsOther
FormDescriptionDateFormat
10-KAnnual report which provides a comprehensive overview of the company for the past yearFeb 24, 2022Open Annual report which provides a comprehensive overview of the company for the past year in HTML.Open Annual report which provides a comprehensive overview of the company for the past year in DOC file.Open Annual report which provides a comprehensive overview of the company for the past year in PDF file.Open Annual report which provides a comprehensive overview of the company for the past year in XLS file.Open Annual report which provides a comprehensive overview of the company for the past year in XBLR Viewer.Open Annual report which provides a comprehensive overview of the company for the past year in XBLR file.
 
PRVB_white_logo@2x.png

Careers Contact Us Terms of Use Privacy Policy Sitemap Provention Bio for Payers


© 2023 Provention Bio, Inc. All rights reserved. PRVB-01 09/20

Provention Bio, Inc.
P.O. Box 666,
Oldwick, NJ 08858,
United States
(908) 336-0360 info@proventionbio.com
Hours
>